Inspire Medical Systems Inc - Asset Resilience Ratio
Inspire Medical Systems Inc (INSP) has an Asset Resilience Ratio of 20.29% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check INSP capital-intensive asset ratio to assess the company's strategic physical and investment asset allocation.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2016–2025)
This chart shows how Inspire Medical Systems Inc's Asset Resilience Ratio has changed over time. See INSP net asset quality score to measure how much of total assets are equity-financed.
Liquid Assets Composition Over Time
This chart breaks down Inspire Medical Systems Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see INSP stock market capitalisation.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0% |
| Short-term Investments | $184.90 Million | 20.29% |
| Total Liquid Assets | $184.90 Million | 20.29% |
Asset Resilience Insights
- Good Liquidity Position: Inspire Medical Systems Inc maintains a healthy 20.29% of assets in liquid form.
- This level provides good financial flexibility while maintaining productive asset deployment.
- The company has significant short-term investments, indicating active treasury management.
Inspire Medical Systems Inc Industry Peers by Asset Resilience Ratio
Compare Inspire Medical Systems Inc's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Double Medical Technology Inc
SHE:002901 |
Medical Devices | 12.59% |
|
Shenzhen New Industries Biomedical
SHE:300832 |
Medical Devices | 9.95% |
|
Shanghai MicroPort EV MedTech Co. Ltd. A
SHG:688351 |
Medical Devices | 49.23% |
|
L&C Bio Co. Ltd
KQ:290650 |
Medical Devices | 2.14% |
|
INKON Life Technology Co Ltd
SHE:300143 |
Medical Devices | 5.73% |
|
Shenzhen Lifotronic Technology Co
SHG:688389 |
Medical Devices | 2.53% |
|
Shanghai General Healthy Information and Technology Co. Ltd.
SHG:605186 |
Medical Devices | 0.84% |
|
Eurobio Scientific SA
PA:ALERS |
Medical Devices | 10.52% |
Annual Asset Resilience Ratio for Inspire Medical Systems Inc (2016–2025)
The table below shows the annual Asset Resilience Ratio data for Inspire Medical Systems Inc.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 22.42% | $203.46 Million | $907.32 Million | -14.12pp |
| 2024-12-31 | 36.54% | $295.40 Million | $808.38 Million | -4.07pp |
| 2023-12-31 | 40.61% | $274.84 Million | $676.81 Million | +38.87pp |
| 2022-12-31 | 1.74% | $9.82 Million | $564.88 Million | -- |
| 2021-12-31 | 0.00% | $0.00 | $295.08 Million | -- |
| 2020-12-31 | 15.59% | $43.84 Million | $281.19 Million | -54.26pp |
| 2019-12-31 | 69.85% | $126.61 Million | $181.25 Million | +24.41pp |
| 2018-12-31 | 45.44% | $90.92 Million | $200.08 Million | +16.80pp |
| 2017-12-31 | 28.65% | $7.19 Million | $25.09 Million | -- |
| 2016-12-31 | 0.00% | $0.00 | $13.12 Million | -- |
About Inspire Medical Systems Inc
Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for patients with moderate to severe OSA. It also develop… Read more